An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
NCT05433090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2026-03-31
Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
Conditions
Interventions
- BEHAVIORAL
-
Inpatient serious illness care program
Inpatient advance care planning intervention that will be delivered by advanced care practitioners or hematology/oncology fellow physicians. The intervention will be an adapted version of the serious illness care program.
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Kah Poh Loh · University of Rochester
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-23
- Primary Completion
- 2024-08-23
- Completion
- 2024-11-14
Countries
- United States
Study Locations
More Related Trials
-
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
NCT07263074 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
NCT02101983 ·Status: COMPLETED ·Phase: NA
-
Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
NCT07250217 ·Status: RECRUITING ·Phase: NA
-
Early Palliative Care for Patients With Haematological Malignancies
NCT03800095 ·Status: UNKNOWN ·Phase: PHASE3
-
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT02042690 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
NCT03023384 ·Status: UNKNOWN
-
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
NCT02756962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival
NCT01188330 ·Status: UNKNOWN ·Phase: NA
-
High-dose Cytarabine and Survival in AML
NCT01034839 ·Status: COMPLETED
-
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML
NCT05309018 ·Status: WITHDRAWN
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
NCT05902416 ·Status: RECRUITING
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
NCT03499912 ·Status: UNKNOWN
-
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.
NCT03350152 ·Status: COMPLETED
-
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
NCT01976442 ·Status: COMPLETED
-
De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)
NCT03462095 ·Status: UNKNOWN ·Phase: NA
-
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases
NCT03959007 ·Status: COMPLETED ·Phase: NA
-
Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission
NCT04914676 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
NCT04582604 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258 ·Status: RECRUITING
-
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
NCT06990321 ·Status: RECRUITING ·Phase: PHASE3
-
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.
NCT06946602 ·Status: NOT_YET_RECRUITING ·Phase: NA